Scoopfeeds — Intelligent news, curated.
Barclays reiterates uniQure stock rating after FDA meeting update
business

Barclays reiterates uniQure stock rating after FDA meeting update

Investing.com · Jun 17, 2026, 2:05 PM · Also reported by 1 other source

Barclays reiterates uniQure stock rating after FDA meeting update

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop